Allianz Asset Management
TXG icon

Allianz Asset Management’s 10x Genomics TXG Stock Holding History

Allianz Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1M Buy
368,214
+48,205
+15% +$1.26M 0.01% 913
2026
Q1 		$6.79M Buy
+320,009
New +$6.4M 0.01% 1032
2025
Q2 		– Sell
-63,600
Closed -$555K – 2307
2025
Q1 		$555K Buy
63,600
+35,600
+127% +$449K ﹤0.01% 1844
2024
Q4 		$402K Hold
28,000
– – ﹤0.01% 1924
2024
Q3 		$632K Buy
+28,000
New +$579K ﹤0.01% 1787
2024
Q2 		– Sell
-6,200
Closed -$233K – 2259
2024
Q1 		$233K Buy
6,200
+600
+11% +$26.4K ﹤0.01% 1816
2023
Q4 		$313K Buy
+5,600
New +$244K ﹤0.01% 1968
2022
Q1 		– Sell
-141,261
Closed -$21M – 2661
2021
Q4 		$21M Buy
141,261
+9,174
+7% +$1.41M 0.01% 750
2021
Q3 		$19.2M Buy
132,087
+13,300
+11% +$2.28M 0.01% 757
2021
Q2 		$23.3M Sell
118,787
-20,883
-15% -$3.78M 0.02% 591
2021
Q1 		$25.3M Buy
139,670
+85,844
+159% +$14.8M 0.02% 538
2020
Q4 		$7.62M Buy
53,826
+9,813
+22% +$1.42M 0.01% 928
2020
Q3 		$5.49M Buy
44,013
+39,773
+938% +$4.17M 0.01% 950
2020
Q2 		$379K Buy
+4,240
New +$330K ﹤0.01% 2135

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Allianz Asset Management's TXG Position: Q2 2026 in Review

Allianz Asset Management increased its 10x Genomics (TXG) stake by 15% in Q2 2026, buying an estimated $1.26M and bringing the position to 368,214 shares worth $14.1M. The position accounts for 0.01% of the portfolio, ranked #913.

Allianz Asset Management first reported a position in TXG in Q2 2020 and has held it in 14 quarters since. The position peaked at $25.3M in Q1 2021. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Allianz Asset Management held 368,214 shares of 10x Genomics worth $14.1M as of Q2 2026.
  • Allianz Asset Management bought 48,205 10x Genomics shares in Q2 2026, an estimated $1.26M.
  • 10x Genomics made up 0.01% of Allianz Asset Management's portfolio in Q2 2026, its #913 holding.
  • Allianz Asset Management first reported a position in 10x Genomics in Q2 2020 and has held it in 14 quarters since.
  • Allianz Asset Management's 10x Genomics position peaked at $25.3M in Q1 2021.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.